Pemigatinib in previously treated Chinese patients with locally advanced or meta
- This topic has 0 replies, 1 voice, and was last updated 1 year, 9 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Pemigatinib in previously treated Chinese patients with locally advanced or metastatic cholangiocarcinoma carrying FGFR2 fusions or rearrangements: A phase II study
https://pubmed.ncbi.nlm.nih.gov/36127767/
Viewing 1 post (of 1 total)
- The forum ‘Chemotherapy & More’ is closed to new topics and replies.